| scholarly article | Q13442814 |
| editorial | Q871232 |
| P2093 | author name string | Stone RM | |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myelodysplastic syndrome | Q954625 |
| P304 | page(s) | 3437-3440 | |
| P577 | publication date | 1994-06-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress | |
| P478 | volume | 83 |
| Q35848136 | Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia |
| Q35005506 | Cyclophosphamide and cancer: golden anniversary |
| Q77466429 | Early fulminant leukaemia post autologous bone marrow transplantation in non-Hodgkin's lymphoma patients |
| Q35117677 | Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors |
| Q36619788 | High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. |
| Q34996344 | Important features of myelodysplastic syndrome |
| Q35327266 | Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors |
| Q36615187 | Second primary malignancies after treatment for malignant lymphoma. |
| Q37824996 | Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia |
| Q35678455 | Subsequent malignant neoplasms after hematopoietic cell transplantation |
| Q37402657 | Therapy-related myelodysplasia and acute myeloid leukemia |
| Q28071318 | Therapy-related myeloid neoplasms - what have we learned so far? |
Search more.